Then, we used UALCAN to further explore the relationship between the mRNA expression of IGF2BP2 and clinicopathological parameters in HNSC patients (age, gender, cancer stages, tumor grades, HPV status). The gene discussed is IGF2BP2; the disease is neoplasm.